Valuation: QuidelOrtho Corporation

Market Cap 739M 656M 612M 558M 1.05B 71B 1.06B 7.41B 2.87B 36.3B 2.77B 2.71B 116B P/E 2026 *
-2.62x
P/E 2027 * -3.89x
Enterprise Value 3.45B 3.07B 2.86B 2.61B 4.92B 332B 4.97B 34.64B 13.42B 170B 12.96B 12.68B 544B EV / Sales 2026 *
1.36x
EV / Sales 2027 * 1.3x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day+3.76%
1 week-1.55%
Current month+2.18%
1 month-22.68%
3 months-40.99%
6 months-37.57%
Current year-62.29%
1 week 9.93
Extreme 9.93
11.18
1 month 9.93
Extreme 9.93
14
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
75.86
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 06/05/2024
Director of Finance/CFO 48 06/07/2026
Chief Operating Officer 57 15/11/2024
Director TitleAgeSince
Chairman 72 11/12/2022
Director/Board Member 71 01/01/2022
Director/Board Member 82 01/01/1993
Date Insider Type Main position Quantity % Market Cap. Importance
9/15/26 A Exercice

Head of Human Resources

6,053 0.0088%
8/15/26 A Exercice

EVP Global Port. Mgmt & Mkting

1,054 0.0015% -
7/15/26 A Free

Chief Financial Officer

356,555 0.5251%
Change 5-day change 1-year change 3-year change Capi.($)
+3.76%-1.55%-64.08%-85.24% 739M
+0.35%-2.99%+20.52%+31.06% 242B
+1.09%-4.65%-0.43%-0.76% 150B
-2.32%-3.27%-13.35%+36.07% 138B
-1.46%-3.01%-56.23%-17.35% 61.74B
-0.05%-1.32%+10.48%+22.34% 49.08B
+0.66%+0.19%-20.53%-20.70% 47.43B
+0.66%-2.90%+18.46%+52.17% 47.3B
-3.05%-2.62%-7.75%+36.49% 44.25B
-0.08%-1.92%+29.48%+60.45% 41.78B
Average -0.04%-2.41%-8.34%+11.45% 82.34B
Weighted average by Cap. -0.29%-3.27%+1.02%+21.85%

Financials

2026 *2027 *
Net sales 2.54B 2.26B 2.11B 1.92B 3.63B 245B 3.66B 25.53B 9.89B 125B 9.55B 9.35B 401B 2.59B 2.3B 2.15B 1.96B 3.69B 249B 3.73B 26.01B 10.08B 127B 9.73B 9.52B 409B
Net income -282M -250M -233M -213M -401M -27.07B -405M -2.83B -1.09B -13.84B -1.06B -1.03B -44.41B -190M -169M -158M -144M -271M -18.29B -274M -1.91B -740M -9.35B -714M -699M -30.01B
Net Debt 2.71B 2.41B 2.25B 2.05B 3.87B 261B 3.9B 27.22B 10.55B 133B 10.18B 9.96B 428B 2.62B 2.33B 2.18B 1.98B 3.74B 252B 3.78B 26.34B 10.21B 129B 9.85B 9.64B 414B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
02/10/26 $10.77 +3.76% 2,417,486
01/10/26 $10.38 -1.52% 2,768,533
30/09/26 $10.54 -0.52% 1,376,265
29/09/26 $10.60 -2.17% 895,466
28/09/26 $10.83 -1.01% 760,160
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
10.77USD
Average target price
14.67USD
Spread / Average Target
+36.18%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock